ReviewBMC ophthalmology2025
Ocular inflammation as the first presenting feature of PRF1-associated familial hemophagocytic lymphohistiocytosis, case report and review of literature.
Review in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHemophagocytic lymphohistiocytosis (HLH) is a syndrome of hyperinflammation. It is categorized into a primary or secondary form. Familial HLH is considered a subset of primary HLH that results from a biallelic mutation in one of the four genes that regulate granule-dependent cytotoxicity: PRF1, UNC13D, STX11, and STXBP2. The reported ocular findings in association with HLH are diverse and variable, with few reports in particular in patients with primary HLH. As far as our knowledge goes, this is the first documented instance of a genetically confirmed case of PRF1-associated familial HLH with this specific presentation. CASE PRESENTATION: A previously healthy 11-year-old boy presented with a one-week history of acute esotropia. A dilated fundus exam revealed peripheral snowballs with multiple areas of perivascular sheathing bilaterally with corresponding focal vascular leakage on fundus fluorescein angiography (FFA). Complete systemic workup, including brain magnetic resonance imaging (MRI), showed hyperintensities involving brain parenchyma, cerebellum, and a short spinal cord segment. The neurological exam and lumbar puncture results were within normal at that time. However, later on, the patient presented with progressively worsening systemic manifestations, including ataxic gait, dysarthria, and upper and lower limb weakness. Multiple treatment regimens were initiated without significant improvement, including intravenous methylprednisolone, intravenous immunoglobulins, and plasma exchange. Whole-exome sequencing (WES) revealed a pathogenic homozygous missense mutation (c.1081 A > T p.(Arg361Trp)) in the PRF1 gene, confirming the diagnosis of familial hemophagocytic lymphohistiocytosis. HLH treatment protocol was initiated, and the patient was transferred to another center for a hematopoietic stem cell transplantation (HSCT).
conclusionThis report describes a case of PRF1-associated familial HLH with unusual initial ocular presentation, highlighting the importance of a thorough systemic workup and the consideration of this rare diagnosis for such findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.